Lv1
30 积分 2025-08-13 加入
Factor D
11小时前
待确认
Danicopan: First Approval
13小时前
已完结
Complement factor D is a drug target for metabolic-associated fatty liver disease
4天前
已完结
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
5天前
已完结
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
5天前
已完结
The complement system: Biology, pathology, and therapeutic interventions
8天前
已完结
Age-related macular degeneration
8天前
已关闭
Therapeutic targeting of neuroimmune mechanisms in neurodegeneration
19天前
已完结
Correlations of the Complement Proteins MASP‐2 and MASP‐3 With Clinical Severity and Short‐Term Outcomes in Primary Membranous Nephropathy Patients
1个月前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
1个月前
已完结
Indirect Effect Model with Surge-Function for Describing Melatonin Circadian Rhythm: Quantitative Comparison and Application Between Normal Sleepers and Patients with Delayed Sleep-Wake Phase Disorder
皖公网安备34019202002308
